Trouble might lie ahead for Skymall. Rohin Dhar makes the case in The Atlantic that everybody’s favorite in-flight magazine might’ve just merged with a dubious “nutraceuticals” company in need of SEC scrutiny.
Trouble might lie ahead for Skymall. Rohin Dhar makes the case in The Atlantic that everybody’s favorite in-flight magazine might’ve just merged with a dubious “nutraceuticals” company in need of SEC scrutiny.